ISELIN, N.J., May 14 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) announced today that its President and Chief Financial Officer, S. Colin Neill, will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 5:15 PM Central Europe Daylight Time (GMT +2:00, or 11:15 AM Eastern Daylight Time). The conference is taking place May 19-20, 2008 at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
In the presentation, Mr. Neill will provide an update on the Company's business and product pipeline. A webcast of the presentation will be available and archived for 90 days after the conference at http://www.wsw.com/webcast/rrshq13/pars. For additional information on this conference please visit http://www.rodmanandrenshaw.com/conferences?id=18.
About Pharmos Corporation
Pharmos Corporation is a biopharmaceutical company that discovers and
develops novel therapeutics to treat a range of diseases of the nervous
system, including disorders of the brain-gut axis, with a focus on
pain/inflammation and autoimmune disorders. The Company's lead product,
dextofisopam, is being studied in a Phase 2b clinical trial in patients
with IBS. Dextofisopam has completed a Phase 2a IBS study in which it
demonstrated a statistically significant effect compared to placebo on the
primary efficacy endpoint of adequate relief (n=141, p=0.033) and was very
well tolerated. A second program in Phase 2a involves a clinical trial of
our NanoEmulsion cream drug delivery system to deliver the NSAID diclofenac
topically in patients suffering from osteoarthr
|SOURCE Pharmos Corporation|
Copyright©2008 PR Newswire.
All rights reserved